Liu T, Fujita T, Kumamoto E. Acetylcholine and norepinephrine mediate GABAergic but not glycinergic transmission enhancement by melittin in adult rat substantia gelatinosa neurons. J Neurophysiol 106: 233-246, 2011. First published April 27, 2011 doi:10.1152/jn.00838.2010.-GABAergic and glycinergic inhibitory synaptic transmissions in substantia gelatinosa (SG; lamina II of Rexed) neurons of the spinal dorsal horn play an important role in regulating nociceptive transmission from the periphery. It has not yet been well known whether each of the inhibitory transmissions plays a distinct role in the regulation. We report an involvement of neurotransmitters in GABAergic but not glycinergic transmission enhancement produced by the PLA 2 activator melittin, where the wholecell patch-clamp technique is applied to the SG neurons of adult rat spinal cord slices. Glycinergic but not GABAergic spontaneous inhibitory postsynaptic current (sIPSC) was increased in frequency and amplitude by melittin in the presence of nicotinic, muscarinic acetylcholine, and ␣ 1 -adrenergic receptor antagonists (mecamylamine, atropine, and WB-4101, respectively). GABAergic transmission enhancement produced by melittin was unaffected by the 5-hydroxytryptamine 3 receptor and P2X receptor antagonists 930 and pyridoxalphosphate-6-azophenyl-2=,4=-disulphonic acid, respectively). Nicotinic and muscarinic acetylcholine receptor agonists [(Ϫ)-nicotine and carbamoylcholine, respectively] and norepinephrine, as well as melittin, increased GABAergic sIPSC frequency and amplitude. A repeated application of (Ϫ)-nicotine, carbamoylcholine, and norepinephrine, but not melittin, at an interval of 30 min produced a similar transmission enhancement. These results indicate that melittin produces the release of acetylcholine and norepinephrine, which activate (nicotinic and muscarinic) acetylcholine and ␣ 1 -adrenergic receptors, respectively, resulting in GABAergic but not glycinergic transmission enhancement in SG neurons.
pain; phospholipase A 2 ; inhibitory transmission A NEURONAL CIRCUITRY IN THE superficial dorsal horn, particularly the substantia gelatinosa (SG; lamina II of Rexed), plays an important role in modulating nociceptive transmission to the central nervous system (CNS) from the periphery through glutamatergic primary-afferent fibers (for review, see Mason 1999; Melzack and Wall 1965; Willis and Coggeshall 1991) . Glutamatergic excitatory synaptic transmission in SG neurons is inhibited by a variety of endogenous and exogenous analgesics, including opioids (Fujita and Kumamoto 2006; Kohno et al. 1999; Wu et al. 2003) , baclofen (Blake et al. 1993; Iyadomi et al. 2000) , nociceptin (Liebel et al. 1997; Luo et al. 2002) , and adenosine (for review, see Fürst 1999; Lao et al. 2004; Li and Perl 1994) . GABAergic and glycinergic inhibitory interneurons in the SG are involved in polysynaptic pathways originating in primary-afferent terminals (Coggeshall and Carlton 1997; Todd et al. 1996; Willis and Coggeshall 1991) and possibly serve to modulate nociceptive transmission. In support of this idea, the lack of the GABAsynthesizing enzyme (Kohno 2007; Moore et al. 2002) and also the reduction in the expression of K ϩ -Cl Ϫ exporter KCC2, which causes an inhibitory synaptic response to be excitatory (Coull et al. 2003) in the rat spinal dorsal horn, lead to nociception. Peripheral inflammation results in a reduced glycinergic transmission in rat spinal lamina I neurons by a presynaptic mechanism (Müller et al. 2003 ). An increase in endogenous glycine due to glycine transporter-1 blockade produces an inhibitory effect on spinal nociceptive transmission (for review, see Sandkühler 2009; Tanabe et al. 2008) .
Phospholipase A 2 (PLA 2 ) plays an important role in nociception through the synthesis of eicosanoids by the actions of cyclooxygenase (COX; for review, see Samad et al. 2002; Svensson and Yaksh 2002; Vanegas and Schaible 2001) and lipoxygenase (LOX; for instance, see Hwang et al. 2000) in the spinal dorsal horn (for review, see Dennis 1994) . There is much evidence supporting this idea. For example, the rat spinal cord contains PLA 2 (Samad et al. 2001) , and peripheral tissue injury and inflammation increase the release of PGE 2 (one of the COX metabolites) and produce PLA 2 -mediated glutamatergic excitatory transmission enhancement in the spinal dorsal horn (Dirig and Yaksh 1999; Young et al. 1995) . Bath-applied PGE 2 produces a membrane depolarization in the SG neurons of rat spinal cord slices (Baba et al. 2001) . PGE 2 inhibits glycinergic inhibitory transmission in rat superficial dorsal horn neurons (Ahmadi et al. 2002; for review, see Zeilhofer 2005) . Hwang et al. (2000) have demonstrated that the metabolites of LOX directly activate the transient receptor potential type-1 channel, which plays a role in regulating nociceptive transmission in the SG (Jiang et al. 2009 ; for review, see Szallasi 2002) .
We have recently revealed that by using a 26-amino acid peptide melittin, PLA 2 activation enhances GABAergic and glycinergic spontaneous inhibitory synaptic transmissions in all of the rat SG neurons examined (Liu et al. 2008 ). This is so, although the SG is composed of a heterogeneous cell group (Grudt and Perl 2002) . The glycinergic transmission enhancement was due to PLA 2 and subsequent LOX activation at glycinergic synapses, whereas the GABAergic transmission one was suggested to be mediated by neurotransmitters released from neurons as a result of excitatory transmission enhancement caused by PLA 2 activation (see Yue et al. 2005) and subsequent increase in neuronal activities (Liu et al. 2008) . There are a variety of neurotransmitters, such as acetylcholine, norepinephrine, ATP, and serotonin, which are involved in enhancing spontaneous inhibitory transmission in spinal dorsal horn neurons (Abe et al. 2009; Baba et al. 1998 Baba et al. , 2000a Baba et al. , 2000b Fukushima et al. 2009; Kawamata et al. 2003; Kiyosawa et al. 2001; Rhee et al. 2000; Takeda et al. 2003) . The present study examined what kinds of neurotransmitters are involved in the melittin-induced GABAergic spontaneous inhibitory transmission enhancement by applying the whole-cell patch-clamp technique to the SG neurons of adult rat spinal cord slice preparations.
METHODS
This study was approved by the Animal Care and Use Committee of Saga University (Saga, Japan) and was conducted in accordance with the Guiding Principles for the Care and Use of Animals in the Field of Physiological Science of the Physiological Society of Japan. All efforts were made to minimize animal suffering and the number of animals used.
Slice preparation. Spinal cord slices from adult rats were prepared as described previously (Fujita and Kumamoto 2006; Jiang et al. 2009; Liu et al. 2004 Liu et al. , 2008 . In brief, male adult Sprague-Dawley rats (6 -8 wk old) were anesthetized with urethane (1.2 g/kg, ip), and then a laminectomy was performed to extract a lumbosacral spinal cord enlargement (L1-S3). The spinal cord was placed in preoxygenated Krebs solution at 1-3°C. After cutting all of ventral and dorsal roots, the pia-arachnoid membrane was removed. The spinal cord was mounted on a vibrating microslicer, and then a 600-m-thick transverse slice was cut. The slice was placed on a nylon mesh in the recording chamber (0.5-ml vol) and then perfused at a rate of 10 -15 ml/min with Krebs solution, bubbled with 95% O 2 and 5% CO 2 , and maintained at 36 Ϯ 1°C. The Krebs solution contained NaCl 117, KCl 3.6, CaCl 2 2.5, MgCl 2 1.2, NaH 2 PO 4 1.2, NaHCO 3 25, and glucose 11 (in mM; pH ϭ 7.4 when saturated with the gas).
Whole-cell voltage-clamp recordings. The SG was identified as a translucent band under a binocular microscope with light transmitted from below (Fujita and Kumamoto 2006; Jiang et al. 2009; Liu et al. 2004 Liu et al. , 2008 . Blind whole-cell voltage-clamp recordings of spontaneous inhibitory postsynaptic currents (sIPSCs) from the SG neurons were made at a holding potential (V H ) of 0 mV, where glutamatergic spontaneous excitatory postsynaptic currents were invisible because the reversal potential for non-N-methyl-D-aspartate (NMDA) receptor channels involved in this production was close to 0 mV (Iyadomi et al. 2000; Kohno et al. 1999; Liu et al. 2008; Luo et al. 2002; Yang et al. 2004) . Patch pipettes were fabricated from thin-walled, fiber-filled capillaries (1.5 mm OD) and contained the following solution (in mM): Cs 2 SO 4 110, CaCl 2 0.5, MgCl 2 2, EGTA 5, HEPES 5, Mg-ATP 5, and tetraethylammonium (TEA)-Cl 5 (pH ϭ 7.2). Cs ϩ and TEA were added to inhibit K ϩ channels located in the recorded SG neurons and thus to easily shift V H to 0 mV from resting membrane potentials. Signals were acquired using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA). Currents obtained in the voltage-clamp mode were low pass filtered at 5 kHz and digitized at 333 kHz with an analog-to-digital converter (Digidata 1322A, Molecular Devices). The data were stored and analyzed with a personal computer using pCLAMP v 9.2 software (Molecular Devices). The program (AxoGraph 4.0, Molecular Devices) used for analyzing sIPSCs detects spontaneous events if the difference between the baseline and a following current value exceeds a given threshold of 5 pA, and separating valleys are Ͻ50% of adjacent peaks. Width at one-half of the peak of sIPSC was also analyzed by using AxoGraph 4.0.
Application of drugs. Drugs were applied by perfusing a solution containing drugs of a known concentration without an alteration in the perfusion rate and temperature. The solution in the recording chamber having a 0.5-ml vol was completely replaced within 15 s. The drugs used were bicuculline methiodide, TTX (Wako, Osaka, Japan), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), DL-2-amino-5-phosphonovaleric acid (APV; Tocris Cookson, Bristol, UK), atropine sulfate (Tokyo Kasei, Tokyo, Japan), melittin purified from bee venom, 4-bromophenacyl bromide (4-BPB), strychnine nitrate, mecamylamine hydrochloride, (Ϫ)-nicotine, carbamoylcholine, norepinephrine, 930) methiodide, and pyridoxalphosphate-6-azophenyl-2=,4=-disulfonic acid (PPADS; Sigma, St. Louis, MO). These drugs (except for CNQX, where dimethyl sulfoxide was used as solvent) were first dissolved in distilled water at 1,000 times the concentration to be used and then stored at Ϫ20°C. The stock solution was diluted to the desired concentration in Krebs solution immediately before use. When melittin (1 M) was repeatedly superfused in the same spinal cord slice, time intervals between the applications were more than 1 h, unless otherwise mentioned.
Statistical analysis. Numerical data are presented as the mean Ϯ SE. Statistical significance was determined as P Ͻ 0.05 using paired (unless otherwise mentioned) or unpaired Student's t-test or ANOVA, followed by Turkey-Kramer's post hoc test. In all cases, n refers to the number of neurons studied.
RESULTS
SG neurons had resting membrane potentials more negative than Ϫ60 mV when measured in a current-clamp mode just after the establishment of whole-cell mode. When V H was shifted to 0 mV in a voltage-clamp mode, sIPSCs were observed in all SG neurons examined. GABAergic and glycinergic sIPSCs were recorded in the presence of a glycine receptor antagonist strychnine (1 M) and a GABA A receptor antagonist bicuculline (10 M; see Yang et al. 2004) , respectively, unless otherwise mentioned. The effects of various drugs, including melittin (1 M), on the inhibitory synaptic transmission were examined in a total of 133 SG neurons.
The effects of a variety of receptor antagonists on spontaneous inhibitory transmission enhancement produced by melittin in SG neurons. Since the activation of nicotinic and muscarinic acetylcholine receptors enhanced spontaneous inhibitory transmission in adult rat SG neurons (Baba et al. 1998; Kiyosawa et al. 2001; Takeda et al. 2003) , we first examined how GABAergic and glycinergic spontaneous inhibitory transmission enhancements, produced by melittin (1 M), superfused for 3 min, are affected by a nicotinic acetylcholine receptor antagonist mecamylamine (20 M) or a muscarinic acetylcholine receptor antagonist atropine (1 M). In the presence of mecamylamine or atropine, melittin did not significantly enhance GABAergic synaptic transmission, albeit there was a tendency to be enhanced (data not shown). GABAergic sIPSC frequency and amplitude ϳ3 min after the beginning of melittin superfusion in the presence of mecamylamine were, respectively, 184 Ϯ 75% (n ϭ 6; P Ͼ 0.05) and 132 Ϯ 36% (n ϭ 6; P Ͼ 0.05) of control (2.6 Ϯ 0.6 Hz and 11.5 Ϯ 1.0 pA); those in the presence of atropine were, respectively, 132 Ϯ 17% (n ϭ 5; P Ͼ 0.05) and 140 Ϯ 51% (n ϭ 5; P Ͼ 0.05) of control (2.7 Ϯ 0.8 Hz and 12.0 Ϯ 0.7 pA). These GABAergic sIPSC frequency and amplitude percentages were significantly smaller than those (frequency and amplitude: 386 Ϯ 37% and 178 Ϯ 10%, respectively; n ϭ 32; see Liu et al. 2008 ) produced by melittin (1 M) in the absence of these acetylcholine receptor antagonists (P Ͻ 0.05). In the presence of both mecamylamine and atropine, melittin did not affect GABAergic inhibitory transmission, as seen in Fig. 1Aa . Figure 1Ab summarizes data about GABAergic sIPSC frequency and amplitude, as obtained from seven neurons. On the contrary, glycinergic inhibitory transmission was enhanced by melittin (1 M) in the In this and subsequent figures, vertical lines accompanied by bars indicate SE; statistical significance between data shown by bars is indicated by asterisks, *P Ͻ 0.05 and **P Ͻ 0.001; n.s., not significant; comparison between melittin effects in the absence and presence of receptor antagonists is performed by using ANOVA, followed by Turkey-Kramer's post hoc test. GABAergic and glycinergic inhibitory transmissions were recorded in the presence of a glycine receptor antagonist strychnine (1 M) and a GABA A receptor antagonist bicuculline (10 M), respectively. V H ϭ 0 mV. presence of both mecamylamine and atropine, as seen in Fig.  1Ba . Glycinergic sIPSC frequency and amplitude percentages, relative to control, ϳ3 min after the beginning of melittin superfusion (293 Ϯ 34% and 166 Ϯ 17%, respectively; n ϭ 7), were significantly not different from those (frequency and amplitude: 391 Ϯ 36% and 207 Ϯ 13%, respectively; n ϭ 27; see Liu et al. 2008 ) produced by melittin (1 M) in the absence of the acetylcholine receptor antagonists (P Ͼ 0.05), as summarized in Fig. 1Bb .
Since norepinephrine enhanced spontaneous inhibitory transmission in SG neurons by activating ␣ 1 -adrenoceptors (Baba et al. 2000a (Baba et al. , 2000b , we next examined how an ␣ 1 -adrenoceptor antagonist WB-4101 (0.5 M) affects GABAergic and glycinergic spontaneous inhibitory transmission enhancements produced by melittin (1 M). Melittin enhanced glycinergic but not GABAergic inhibitory transmission in the presence of WB-4101, as seen in Fig. 2 , Aa and Ba. Similar actions of melittin on GABAergic and glycinergic inhibitory transmissions were obtained from other four and five neurons, respectively; these results were summarized in Fig. 2 , Ab and Bb.
No effect of acetylcholine receptor and ␣ 1 -adrenoceptor antagonists on glycinergic spontaneous inhibitory transmission enhancement produced by melittin suggests a direct action of melittin on glycinergic transmission, together with the obser- Ab, Bb: sIPSC frequency (left) and amplitude (right) under the action of melittin (measured ϳ3 min after the beginning of its superfusion), relative to those before melittin superfusion, in Krebs solution without (Ab: n ϭ 32; Bb: n ϭ 27; these data were taken from Liu et al. 2008 ) and with WB-4101 [just before melittin superfusion: 2.4 Ϯ 0.8 Hz and 12.9 Ϯ 1.3 pA (n ϭ 5) in Ab; 2.0 Ϯ 0.4 Hz and 11.3 Ϯ 0.6 pA (n ϭ 6) in Bb]. *P Ͻ 0.05; **P Ͻ 0.001; n.s., not significant. GABAergic and glycinergic inhibitory transmissions were recorded in the presence of strychnine (1 M) and bicuculline (10 M), respectively. V H ϭ 0 mV.
vations reported previously that a Na ϩ channel blocker TTX, glutamate receptor antagonists (non-NMDA and NMDA receptor antagonists: CNQX and APV, respectively), and nominally Ca 2ϩ -free solution do not affect melittin-induced glycinergic transmission enhancement (Liu et al. 2008) . On the contrary, the inhibition of GABAergic spontaneous inhibitory transmission enhancement produced by melittin in the presence of acetylcholine receptor or ␣ 1 -adrenoceptor antagonists suggests an involvement of acetylcholine and/or norepinephrine. 5-Hydroxytryptamine 3 (5-HT 3 ) receptor activation produced an increase in GABA release in the rat spinal dorsal horn (Abe et al. 2009; Fukushima et al. 2009; Kawamata et al. 2003) , and ATP enhanced spontaneous inhibitory transmission in rat SG neurons by activating P2X receptors (Rhee et al. 2000) . Therefore, we further examined whether a 5-HT 3 receptor antagonist ICS-205,930 (2 nM; a concentration enough to inhibit presynaptic 5-HT 3 receptors involved in facilitating GABA release in the rat hippocampus; Turner et al. 2004) or P2X receptor antagonist PPADS (10 M; a concentration enough to inhibit P2X receptormediated enhancement of glycine release from nerve terminals in the spinal dorsal horn; Rhee et al. 2000) affects GABAergic spontaneous inhibitory transmission enhancement produced by melittin (1 M). As seen in Fig. 3 , A and B, melittin enhanced GABAergic inhibitory transmission in the presence of ICS-205,930 or PPADS. As summarized in Fig. 3C , melittin-induced GABAergic sIPSC frequency and amplitude increases in the presence of ICS-205,930 or PPADS were not significantly different from those in the absence of the antagonists (P Ͼ 0.05).
GABAergic spontaneous inhibitory transmission was not enhanced by melittin (1 M) under the pretreatment for 4 min with a PLA 2 inhibitor 4-BPB (10 M; Mayer and Marshall 1993), as seen for glycinergic spontaneous transmission (Liu et al. 2008) ; the frequency and amplitude ϳ3 min after the beginning of melittin superfusion were 137 Ϯ 18% (n ϭ 9; P Ͼ 0.05) and 95 Ϯ 5% (n ϭ 9; P Ͼ 0.05), respectively, of control (1.9 Ϯ 0.3 Hz and 10.9 Ϯ 0.6 pA). This result indicates that the melittin-induced GABAergic transmission enhancement is also mediated by PLA 2 , although there is a difference in the sensitivity to cholinergic and ␣ 1 -adrenergic receptor antagonists between GABAergic and glycinergic transmission enhancements produced by melittin.
The effects of melittin, nicotinic, muscarinic acetylcholine receptor agonists, and norepinephrine on GABAergic spontaneous inhibitory transmission in SG neurons. Since GABAergic spontaneous transmission in SG neurons was reported to be enhanced by acetylcholine receptor and ␣ 1 -adrenoceptor agonists (Baba et al. 1998 (Baba et al. , 2000a (Baba et al. , 2000b Takeda et al. 2003) , we examined the effect of a nicotinic, muscarinic acetylcholine receptor agonist [(Ϫ)-nicotine (50 M) and carbamoylcholine (10 M), respectively], or norepinephrine (20 M) on GABAergic spontaneous inhibitory transmission in neurons, where the effect of melittin (1 M) on the inhibitory transmission was examined. These results are given in Figs. 4 , 5, and 6. Approximately 30 min after melittin superfusion, (Ϫ)-nicotine, carbamoylcholine, or norepinephrine, as well as melittin, facilitated GABAergic inhibitory transmission (see Figs. 4 -6, A and  B) , as reported previously (Baba et al. 1998 (Baba et al. , 2000a (Baba et al. , 2000b Takeda et al. 2003) . Similar actions of (Ϫ)-nicotine, carbamoylcholine, and norepinephrine, together with melittin, on GABAergic transmission, were obtained from other eight, nine, and 15 neurons, respectively; these results were summarized in Figs. 4C-6C .
Since a repeated application of melittin (1 M) did not enhance glycinergic spontaneous inhibitory transmission (Liu et al. 2008) , we next examined whether this is so for the melittin-induced enhancement of GABAergic spontaneous inhibitory transmission. Figure 7 demonstrates the effect of a repeated application of melittin (1 M) on GABAergic transmission in the same neuron. When melittin was once again applied 30 min after its washout, the effect of the second application of melittin on GABAergic transmission (Fig. 7B ) was much smaller than that of the first application of melittin (Fig. 7A) . Figure 7C shows a comparison of relative frequency and amplitude of GABAergic sIPSC under the action of melittin with those before its superfusion between the first and second applications, which is obtained from six neurons.
The second application of melittin did not largely affect GABAergic spontaneous inhibitory transmission at 30 min after its first application (Fig. 7) , whereas the transmission was enhanced by (Ϫ)-nicotine, carbamoylcholine, or norepinephrine ϳ30 min after the first application of melittin (Figs. 4 -6 , respectively). These results suggest that a process leading to the release of acetylcholine and/or norepinephrine as a result of melittin action may be slow in recovery. To confirm this idea, we next examined how a repeated application of (Ϫ)-nicotine (50 M), carbamoylcholine (10 M), or norepinephrine (20 M) affects GABAergic spontaneous inhibitory transmission. As seen in Fig. 8 , A-C, each of them repeatedly facilitated GABAergic transmission. The initial application of (Ϫ)-nicotine increased GABAergic sIPSC frequency and amplitude [320 Ϯ 43% (n ϭ 8; P Ͻ 0.05) and 151 Ϯ 12% (n ϭ 8; P Ͻ 0.05), respectively, of control (2.6 Ϯ 0.5 Hz and 10.2 Ϯ 1.0 pA) ϳ1 min after the beginning of its superfusion]. A second application 30 min later increased GABAergic sIPSC frequency and amplitude [288 Ϯ 35% (n ϭ 8; P Ͻ 0.05) and 128 Ϯ 6% (n ϭ 8; P Ͻ 0.05), respectively, of control (2.6 Ϯ 0.5 Hz and 10.0 Ϯ 1.0 pA)]; these percentage values were not significantly different from those of the initial application (P Ͼ 0.05). Similar results were obtained for carbamoylcholine and norepinephrine actions. The initial application of car- 
. Enhancements of GABAergic spontaneous inhibitory transmission by melittin (1 M) and a nicotinic acetylcholine receptor agonist (Ϫ)-nicotine (50 M). A, B: recordings of GABAergic sIPSCs in the absence and presence of melittin (A) or (Ϫ)-nicotine (B).
A and B were obtained from the same neuron; (Ϫ)-nicotine was applied about 30 min after washout of melittin. C: the frequency (left) and amplitude (right) of GABAergic sIPSC under the action of melittin or (Ϫ)-nicotine (measured ϳ3 min after the beginning of its superfusion), relative to control [before melittin and (Ϫ)-nicotine application: 1.1 Ϯ 0.1 Hz and 11.4 Ϯ 0.6 pA (n ϭ 9) and 1.3 Ϯ 0.2 Hz and 12.5 Ϯ 1.0 pA (n ϭ 9), respectively]. *P Ͻ 0.05. Krebs solution contained strychnine (1 M). V H ϭ 0 mV. bamoylcholine increased GABAergic sIPSC frequency and amplitude [321 Ϯ 49% (n ϭ 4; P Ͻ 0.05) and 236 Ϯ 37% (n ϭ 4; P Ͻ 0.05), respectively, of control (3.1 Ϯ 0.3 Hz and 10.0 Ϯ 0.9 pA) ϳ1 min after the beginning of its superfusion]. A second application 30 min later did so with a similar extent; sIPSC frequency and amplitude: 241 Ϯ 12% (n ϭ 4; P Ͻ 0.05) and 206 Ϯ 27% (n ϭ 4; P Ͻ 0.05), respectively, of control (4.1 Ϯ 0.3 Hz and 9.9 Ϯ 0.6 pA). The initial application of norepinephrine increased GABAergic sIPSC frequency and amplitude [470 Ϯ 18% (n ϭ 3; P Ͻ 0.05) and 342 Ϯ 40% (n ϭ 3; P Ͻ 0.05), respectively, of control (1.7 Ϯ 0.4 Hz and 9.2 Ϯ 0.5 pA) ϳ1 min after the beginning of its superfusion]. A second application 30 min later enhanced GABAergic transmission with a similar extent; sIPSC frequency and amplitude: 363 Ϯ 25% (n ϭ 3; P Ͻ 0.05) and 332 Ϯ 34% (n ϭ 3; P Ͻ 0.05), respectively, of control (2.3 Ϯ 0.5 Hz and 10.3 Ϯ 0.9 pA).
Difference in melittin effect between GABAergic and glycinergic spontaneous inhibitory transmissions in the same neuron.
The difference in melittin-induced enhancement in the presence of acetylcholine receptor or ␣ 1 -adrenoceptor antagonist between GABAergic and glycinergic spontaneous inhibitory transmissions was examined in Krebs solution containing strychnine or bicuculline (see Figs. 1 and 2 ). To know whether this difference is seen in Krebs solution without strychnine and bicuculline, we analyzed the one-half width time of sIPSC in the absence and presence of melittin (1 M), recorded in the presence of strychnine or bicuculline. Consistent with the previous observation that the one-half decay time of GABAergic sIPSC is approximately threefold larger than that of glycinergic sIPSC (Kohno et al. 1999; Luo et al. 2002; Yang et al. 2004) , the distribution of the one-half width time of GABAergic sIPSC shifted to a larger one than that of glycinergic sIPSC, as noted in Fig. 9A . In each of GABAergic and glycinergic transmissions, the numbers of events having individual one-half width times of GABAergic or glycinergic sIPSC increased under the action of melittin (see Fig. 9A ). Similar results for GABAergic and glycinergic transmissions were obtained from other five and five neurons, respectively. Averaged one-half width times of GABAergic sIPSC in the control and under the action of melittin were 9.2 Ϯ 0.6 ms (n ϭ 6) and 10.7 Ϯ 0.9 ms (n ϭ 6), respectively; melittin increased a total of its event numbers by 320 Ϯ 70% (n ϭ 6; P Ͻ 0.05). Averaged one-half width times of glycinergic sIPSC in the control and under the action of melittin were 2.9 Ϯ 0.2 ms (n ϭ 6) and 3.8 Ϯ 0.3 ms (n ϭ 6), respectively; melittin increased a total of its event numbers by 520 Ϯ 160% (n ϭ 6; P Ͻ 0.05). The one-half width time of glycinergic sIPSC was significantly smaller than that of GABAergic sIPSC (P Ͻ 0.05; unpaired t-test). Figure 9Ba demonstrates the effect of melittin (1 M) on inhibitory transmission recorded in the presence of TTX (0.5 M), CNQX (10 M), and APV (50 M), where melittin is expected to enhance glycinergic transmission without any change in GABAergic transmission (see Liu et al. 2008) . As noted in Fig. 9Bb , consistent with this expectation, melittin increased the number of events having shorter one-half width time corresponding to that of glycinergic sIPSC (see Fig. 9Ab ), whereas unchanging one having longer one-half width time, which was comparable with that of GABAergic sIPSC (see Fig.  9Aa ). Similar results were obtained from other three neurons. The peak values of the one-half width time of sIPSC under the action of melittin averaged to be 2.8 Ϯ 0.3 ms (n ϭ 4)-values comparable with those of glycinergic sIPSC (2.9 -3.8 ms) but not GABAergic sIPSC (9.2-10.7 ms) as given above.
There was a difference in the melittin effect between GABAergic and glycinergic spontaneous inhibitory transmissions, whereas Jonas et al. (1998) reported that GABA and glycine are coreleased from a single nerve terminal in the neonate rat ventral horn. If such a corelease occurs in the adult rat SG, it is unlikely that GABAergic and glycinergic transmissions are affected by melittin in a manner different from each other. To test the possibility that GABA and glycine are coreleased from SG nerve terminals in rats younger than those used in the present study, we examined how melittin (1 M) affects each of the inhibitory transmissions in SG neurons of young rats (2-3 wk old) in the presence of TTX (0.5 M), CNQX (10 M), and APV (50 M). Melittin enhanced GABAergic but not glycinergic transmission under this condition. Approximately 3 min after the beginning of melittin superfusion, GABAergic sIPSC frequency and amplitude were, respectively, 1,629 Ϯ 875% (n ϭ 3) and 105 Ϯ 18% (n ϭ 3) of control (1.1 Ϯ 0.5 Hz and 8.9 Ϯ 0.5 pA). On the contrary, glycinergic sIPSC frequency and amplitude were, respectively, 76 Ϯ 26% (n ϭ 3) and 80 Ϯ 14% (n ϭ 3) of control (2.8 Ϯ 1.0 Hz and 10.0 Ϯ 1.6 pA; C-Y. Jiang, unpublished observations). This result suggests that GABA and glycine may not be coreleased from SG nerve terminals in young as well as adult rats.
DISCUSSION
The present study demonstrated that a PLA 2 activator melittin increased the frequency and amplitude of GABAergic but not glycinergic sIPSC in adult rat SG neurons in a manner sensitive to nicotinic, muscarinic acetylcholine receptor, and/or ␣ 1 -adrenoceptor antagonists. Nicotinic and musca- . A and B were obtained from the same neuron; norepinephrine was applied about 30 min after washout of melittin. C: the frequency (left) and amplitude (right) of GABAergic sIPSC under the action of melittin or norepinephrine (measured ϳ3 min after the beginning of its superfusion), relative to control [before melittin and norepinephrine application: 2.8 Ϯ 0.4 Hz and 11.9 Ϯ 0.7 pA (n ϭ 16) and 2.8 Ϯ 0.6 Hz and 11.9 Ϯ 0.7 pA (n ϭ 16), respectively]. *P Ͻ 0.05. Krebs solution contained strychnine (1 M). V H ϭ 0 mV. rinic acetylcholine receptor agonists [(Ϫ)-nicotine and carbamoylcholine, respectively] and norepinephrine, as well as melittin, enhanced GABAergic sIPSC frequency and amplitude in SG neurons, suggesting that the GABAergic transmission enhancement produced by melittin was mediated by acetylcholine and norepinephrine released from neurons as a result of an action of melittin. Acetylcholine and norepinephrine released activated (nicotinic and muscarinic) acetylcholine receptors and ␣ 1 -adrenoceptors, respectively. This idea is consistent with our previous observations that the GABAergic but not glycinergic transmission enhancement produced by melittin was reduced in extent in Na ϩ channel blocker TTX-and glutamate receptor antagonist (CNQX and APV)-containing or nominally Ca 2ϩ -free Krebs solution (Liu et al. 2008) . In support of our idea, the spinal dorsal horn, including the SG, contains nicotinic, muscarinic acetylcholine receptor, and ␣ 1 -adrenoceptor subunits (Pieribone et al. 1994; Wada et al. 1989 Wada et al. , 1990 Yamamura et al. 1983 ). The GABAergic transmission enhancements, produced by nicotine, carbamoylcholine, and norepinephrine, have been reported already in adult rat SG neurons (Baba et al. 1998 (Baba et al. , 2000a Takeda et al. 2003 ).
Carbamoylcholine and norepinephrine increased GABAergic sIPSC frequency and amplitude in an action potential-dependent and -independent manner (Baba et al. 1998 (Baba et al. , 2000a , whereas nicotine enhanced GABAergic sIPSC frequency and amplitude without the production of action potentials (Takeda et al. 2003) . These results suggest that the GABAergic sIPSC frequency and amplitude increase produced by melittin are due to an increase in the release of GABA from nerve terminals without and with the production of action potentials in neurons presynaptic to SG neurons as a result of the actions of acetylcholine and norepinephrine. It is unlikely that the GABAergic sIPSC amplitude increase produced by melittin is due to an increase in the affinity of GABA A receptors for GABA, as shown for ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (Bernard et al. 1995; Cruickshank and Henley 1994; Yue et al. 2005) , because this amplitude increase is not seen in the presence of acetylcholine receptor or ␣ 1 -adrenoceptor antagonists.
There are several possible origins of acetylcholine and norepinephrine that may be involved in the melittin action. Immunohistochemical studies of choline acetyltransferase have demonstrated the presence of intrinsic spinal cholinergic neurons in the deep spinal dorsal horn, particularly the lamina III, of adult rats (Borges and Iversen 1986) ; these neurons terminate in the superficial dorsal horn, including the SG (Ribeiro-da-Silva and Cuello 1990). These results are consistent with the observation that a focal stimulation of the deep dorsal horn results in GABAergic spontaneous transmission enhancement similar to that produced by carbamoylcholine in SG neurons (Baba et al. 1998) . Anatomical and behavioral studies have revealed the existence of a descending cholinergic pathway to the spinal dorsal horn from the brain stem in the rat (Jones et al. 1986; Zhuo and Gebhart 1990) . There is much evidence showing the presence of descending norepinephrine-containing fibers to the spinal dorsal horn, particularly the SG, from the brain stem in rats (for review, see Jones 1991; Westlund et al. 1983) . Thus it seems that descending neurons from the brain stem release acetylcholine and norepinephrine in the SG, while acetylcholine also originates from spinal intrinsic neurons. Since a repeated application of (Ϫ)-nicotine, carbamoylcholine, and norepinephrine enhanced GABAergic transmission, whereas melittin did not, acetylcholine and norepinephrine release produced by melittin appeared to be slow in recovery after the release occurred. Such a release of neurotransmitters may be due to an increase in intraterminal Ca 2ϩ concentrations as a result of melittin actions, because melittin increases intracellular Ca 2ϩ concentrations in rat hippocampal mossy fiber nerve endings by activating PLA 2 (Damron and Dorman 1993) . A desensitization of this intracellular pathway leading to neurotransmitter release may result in an inhibition of the effect of the second application of melittin on spontaneous GABAergic transmission. It remains to be examined how melittin action, i.e., PLA 2 activation, results in the release of acetylcholine and norepinephrine from the neurons.
The present and our previous observations (Liu et al. 2008 ) indicate that melittin increases GABAergic and glycinergic sIPSC frequency in a manner different from each other. This difference between GABAergic and glycinergic transmissions was also observed in the absence of both bicuculline and strychnine (see Fig. 9 ). The glycinergic sIPSC frequency increase produced by melittin was significantly unaffected by acetylcholine receptor or ␣ 1 -adrenoceptor antagonists, suggesting that even if acetylcholine and norepinephrine are released as a result of melittin action, they do not enhance glycinergic sIPSC frequency in spite of their ability to increase the frequency in SG neurons (Baba et al. 2000b; Kiyosawa et al. 2001; Takeda et al. 2003) . Altogether, our results suggest that GABA and glycine may be released from a different nerve terminal containing either GABA or glycine. This result in the SG is different from those in the adult rat lamina I (Chéry and de Koninck 1999) and also in the neonate rat ventral horn (Jonas et al. 1998) , where GABA and glycine are thought to be coreleased from a single nerve terminal. The difference between our and previous other studies does not appear to be due to a distinction in age among the rats used, because the difference in the melittin effect between GABAergic and glycinergic transmissions was seen in young rats (2-3 wk old), where GABAergic but not glycinergic transmission was enhanced by melittin in the presence of TTX, CNQX, and APV. This result was reversed to that in adult rats (see Fig. 9Ba ). This reversal may be attributed to a developmental change in processes, such as melittin-mediated PLA 2 activation leading to neurotransmitter release enhancement. This issue remains to be further examined.
Our idea that GABA and glycine may not be coreleased is supported by an immunohistochemical observation that some presynaptic terminals in the SG contain GABA without glycine (Spike and Todd 1992) . Such GABAergic terminals may originate from neurons located in laminae deeper than the SG (Todd and Sullivan 1990) or from descending nerve fibers in the rostral ventromedial medulla (Antal et al. 1996) ; the latter idea is supported by a direct GABAergic inhibition of the SG from the rostral ventromedial medulla, as revealed by in vivo patch-clamp recordings (Kato et al. 2006) . Moreover, neuropeptide Y, galanin, and enkephalin, which are identified in GABAergic interneurons in laminae I-III of the dorsal horn, have been reported to be restricted to those neurons that are not glycinergic (Todd and Koerber 2005). Alternatively, Baba et al. (2000b) have demonstrated that a one-half maximal effective concentration for norepinephrine in increasing GABAergic sIPSC frequency (29.5 M) is different from that for glycinergic sIPSC frequency (38.8 M) in SG neurons.
GABAergic and glycinergic inhibitory transmissions in the superficial dorsal horn are modulated by opioids, nociceptin, nicotine, and adenosine in a manner similar to each other. A -opioid receptor agonist [(D-Ala 2 , N-Me-Phe 4 , Gly-ol 5 ) enkephalin] and nociceptin did not affect both GABAergic and glycinergic inhibitory transmissions in SG neurons (Kohno et al. 1999; Luo et al. 2002) . Nicotine increased GABAergic and glycinergic sIPSC frequency in SG neurons by almost the same extent (Takeda et al. 2003) . Yang et al. (2004) have reported that GABAergic and glycinergic sIPSC frequency in SG neurons is reduced by adenosine with almost the same one-half maximal effective concentration. On the other hand, glycinergic but not GABAergic inhibitory transmission in the superficial dorsal horn was inhibited by PGE 2 ; this inhibition was postsynaptic in origin, i.e., a modulation of glycine but not GABA A receptor channels by PGE 2 (Ahmadi et al. 2002; Zeilhofer 2005 ). The present study revealed that GABAergic but not glycinergic sIPSC frequency in SG neurons is augmented by acetylcholine and norepinephrine, released as a Note that the number of GABAergic sIPSCs, indicated by arrowheads above the lower traces, does not increase under the action of melittin. Bb: histograms of the one-half width times of GABAergic and glycinergic sIPSCs in the control (black columns) and under the action of melittin (gray columns). It is noted that melittin increased the event numbers of one-half width times of sIPSCs corresponding to glycinergic (Ab) but not GABAergic ones (Aa). B, a and b: obtained from the same neuron. GABAergic and glycinergic sIPSCs (A) were recorded in the presence of strychnine (1 M) and bicuculline (10 M), respectively, whereas sIPSCs (B) were in the absence of both of the antagonists. V H ϭ 0 mV. result of melittin action and thus PLA 2 activation. This is, to our knowledge, the first demonstration of a clear-cut difference in presynaptic modulation between GABAergic and glycinergic transmissions in the spinal cord.
Physiological significance of GABAergic inhibitory transmission enhancement mediated by acetylcholine and norepinephrine.
A neuronal circuitry in the SG plays an important role in modulating nociceptive transmission to the CNS from the periphery (Mason 1999; Melzack and Wall 1965; Willis and Coggeshall 1991) . PLA 2 activation in the SG may occur following a repeated application of mustard oil to the periphery (Young et al. 1995) . Alternatively, PLA 2 in the SG may be activated by a peptide analogous to melittin in the mammal (Clark et al. 1991) or an increase in intracellular Ca 2ϩ concentration due to an increase in synaptic activities, such as an excess of glutamate receptor activation (for review, see Meller and Gebhart 1994; Williams et al. 1989) . There is much evidence showing that acetylcholine and norepinephrine released following PLA 2 activation, as suggested in the present study, are involved in inhibiting nociceptive transmission in the spinal dorsal horn. When administered intrathecally, acetylcholine and norepinephrine produce antinociception (Abram and O'Connor 1995; Abram and Winne 1995; Howe et al. 1983; Khan et al. 1998 Khan et al. , 2001 Reddy et al. 1980) . Mice lacking muscarinic acetylcholine receptor M2-type or nicotinic acetylcholine receptor ␣ 4 and ␤ 2 subunits display a reduction in antinociception produced by agonists of the receptors, as assessed in the hot plate and tail-flick tests (Gomeza et al. 1999; Marubio et al. 1999) . The antinociceptive actions mediated by acetylcholine and norepinephrine have been partly attributed to their facilitatory actions on GABAergic and glycinergic inhibitory transmissions, which are expected to reduce the excitability of SG neurons (Baba et al. 1998 (Baba et al. , 2000a (Baba et al. , 2000b Takeda et al. 2003) . Such a GABAergic inhibitory transmission enhancement as that produced by melittin and thus PLA 2 activation, revealed in the present study, could contribute to antinociception. Considering that such a melittin action is not observed for glycinergic transmission, GABAergic and glycinergic inhibitory transmissions in the SG may play a distinct role in regulating nociceptive transmission.
